JEFFREY S MATHIESEN Insider Trading $SNBP Panbela Therapeutics, Inc.
Get free email notifications about insider trading for JEFFREY S MATHIESEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY S MATHIESEN. JEFFREY S MATHIESEN is Vice President and CFO in DELPHAX TECHNOLOGIES INC ($DLPX) and Director in NEUROONE MEDICAL TECHNOLOGIES Corp ($NMTC) and Director in Sun BioPharma, Inc. ($SNBP) and Chief Financial Officer in Gemphire Therapeutics Inc. ($GEMP).
Over the past year JEFFREY S MATHIESEN has been an insider in 2 companies. The total value of shares held by JEFFREY S MATHIESEN in these companies amounts to $63,443.
JEFFREY S MATHIESEN ranks 31,231 out of 350,000 insiders. Go to Insider Ranking to see more.
JEFFREY S MATHIESEN in Panbela Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY S MATHIESEN: Director
Holdings: 5,875 shares
Current Value: $10,281
Latest Transaction: Dec 03 2020
$SNBP Market Capitalization: $56.31M
$SNBP Previous Close: $1.75
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY
Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 5,875
Shares Sold: 0
Share Difference: +5,875
Value Difference: $0
Latest Insider Trading Transactions of JEFFREY S MATHIESEN in Panbela Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DLPX, GEMP, NMTC, SNBP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 03 2020 | SNBP | Panbela Therapeuti ... | MATHIESEN JEFFREY S | Director | Grant | A | 0.00 | 2,875 | 0 | 5,875 | 3 K to 5.9 K (+95.83 %) |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 4.98 | 13,700 | 68,226 | 13,700 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 2.95 | 6,800 | 20,060 | 6,800 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 2.95 | 27,000 | 79,650 | 27,000 | |
| Feb 22 2018 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | P | 5.00 | 3,000 | 15,000 | 3,000 | |
| Feb 22 2018 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Buy | P | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 1.51 | 208,000 | 314,080 | 208,000 |
Page: 1